Reuters logo
BRIEF-Aerie Pharmaceuticals announces FDA advisory committee meeting for Rhopressa™
September 20, 2017 / 8:15 PM / 3 months ago

BRIEF-Aerie Pharmaceuticals announces FDA advisory committee meeting for Rhopressa™

Sept 21 (Reuters) - Aerie Pharmaceuticals Inc

* Aerie Pharmaceuticals Inc announces FDA advisory committee meeting for Rhopressa™ (netarsudil ophthalmic solution) 0.02 pct

* Aerie Pharmaceuticals Inc - FDA set a PDUFA goal date of February 28, 2018 for completion of its review of Rhopressa™ NDA

* Aerie Pharmaceuticals Inc - ‍meeting of dermatologic and ophthalmic drugs advisory committee of FDA scheduled for Oct 13 to review co’s NDA for Rhopressa​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below